UCSF and Zcube have entered into a new agreement to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.

UCSF has received $48 million from the estate of Nina Ireland, a long-time supporter of UCSF, to further the university’s leadership in studying and treating a host of complex pulmonary conditions.